Address: C76, Balewadi, Pune, Maharashtra
Global Cardiac Ablation Market is anticipated to rise at a value CAGR of 12.45% over 2019-2028. According to a study published by Insure Insights on the Global Cardiac Ablation Market. Cardiac ablation is a process that is used to scar small areas in the heart that causes heart rhythm problems. Thus can prevent the abnormal electrical signals or rhythms of the heart. Long, flexible tubes known as catheters are inserted through a vein or artery into the heart to transport energy in the form of heat or extreme cold to adjust the tissues in the heart that cause arrhythmia. The rise in the Healthcare expenditure is driving the market growth
Top Driver: The surge in Cardiovascular disorders around the globe.
The rise in the occurrence of Cardiovascular disorders around the globe, and the lifestyle habits like smoking, and consumption of alcohol are the primary factors driving the market growth. The surge in the elderly population and disorders like diabetes mellitus, mental stress has triggered the market revenue. Technological advancements, rise in the R&D investments, and favorable reimbursement scenario has significantly impacted the growth of the market.
RF ablators have made the highest segmental growth in the Global Cardiac Ablation Market
Based on the Product, Radiofrequency (RF) ablators segment, have dominated the segmental growth due to the importance of radiofrequency (RF) ablators as it is widely used due to its high effectivity of as compared with other devices. RF ablators are considered as safe, reliable than others. These radiofrequency ablators offer an option of customization during the procedure; therefore, it is given more preference over others. Radiofrequency ablators are widely available and thus have boosted the overall, market
In terms of the Applications, Cardiac rhythm management segment has obtained the most remarkable growth owing to the rise in the incidences of people suffering from atrial fibrillation, and thus the need for efficient cardiac rhythm management has boosted the demand for cardiac ablation. In terms of the End User, Hospitals segment have obtained the most significant growth owing to the availability of better healthcare infrastructure and technologically advanced systems.
North America boosts the regional market due to the presence of key players
North America has held the highest market growth owing to the presence of key players like Advanced Cardiac Therapeutics, Alcon Laboratories Inc., AngioDynamics, Inc., etc. The rise in R&D investments and favorable reimbursement have escalated the market revenue of the region. Government initiatives for better patient’s care, technological advancements are further boosting the market growth. The rise in the geriatric population and lifestyle habits like consumption of alcohol and smoking have further contributed to the regional growth. The rise in medical tourism has significantly driven regional market growth
Product launches, Strategic Collaborations, Mergers, and Acquisition, are the major strategies of the competitors
The Players of the Global Cardiac Ablation Market is fragmented. Product launches, Collaborations, Mergers, and Acquisition, are strategies used by the competitors The key competitors of the Global Cardiac Ablation Market are Boston Scientific Corporation, Advanced Cardiac Therapeutics, Alcon Laboratories Inc., AngioDynamics, Inc., AtriCure, Inc., Biosense Webster Inc., CONMED Corporation, Medtronic Plc, Olympus Corporation and St Jude Medical, Inc.
Medtronic Plc: Medtronic Plc, is one of the key competitors of the Global Cardiac Ablation Market; for instance, In June 2019, Medtronic Plc, had announced the acquisition of Epix Therapeutics, they are involved in the manufacturing of the Cardiac Ablation system. The deal was done for USD 316 million. The acquisition was made by Medtronic to strengthen its product portfolio with Cardiac Ablation systems.
Boston Scientific Corporation: Boston Scientific Corporation is a popular competitor in the Global Cardiac Ablation Market. In August 2019, Boston Scientific Corporation had announced the acquisition of BTG; they are involved in the manufacturing of the minimally invasive device. The deal was done for USD 4.2 billion. The acquisition was made by Boston Scientific to strengthen its product portfolio in Patient care systems.
Scope of the Report
By Product
By Application
By End User
By Region
Key Reasons to Purchase this Report
Chapter 2 Our Research Practice
Chapter 4 Covid-19 Impact Analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Cardiac Ablation Market Forces
5.2 Porter’s Five Forces Analysis
5.2.2 Threats From New Entrants
5.2.4 Threat From Substitute Product
Chapter 6 Global Cardiac Ablation Market -Industry Snapshots
6.1.1 Global Cardiac Ablation Market Value, 2019 – 2028, (US$ Bn)
6.2.2 Restraint/Challenges analysis
6.3 Supply Chain/Value Chain Analysis
Chapter 7 Global Cardiac Ablation Market Analysis, by Product
7.2 Key Findings for Cardiac Ablation Market- By Product
7.2.1 Cardiac Ablation Market- Radiofrequency (RF) Ablators
7.2.2 Cardiac Ablation Market- Electrical Ablators
7.2.3 Cardiac Ablation Market- Others
Chapter 8 Global Cardiac Ablation Market Analysis, by Application
8.2 Key Findings for Cardiac Ablation Market- By Application
8.2.1 Cardiac Ablation Market- Cardiac Rhythm Management
8.2.2 Cardiac Ablation Market- Open surgery
8.2.3 Cardiac Ablation Market- Others
Chapter 9 Global Cardiac Ablation Market Analysis, by End User
9.2 Key Findings for Cardiac Ablation Market- By End User
9.2.1 Cardiac Ablation Market- Hospitals
9.2.2 Cardiac Ablation Market- Ambulatory surgical centers
9.2.3 Cardiac Ablation Market- Cardiac centers
Chapter 10 Cardiac Ablation Market Analysis by Region
10.1 Key Findings for Cardiac Ablation Market- By region
10.2.1 Global Cardiac Ablation Market Analysis, By Product, 2019 – 2028
10.2.2 Global Cardiac Ablation Market Analysis, By Application, 2019 – 2028
10.2.3 Global Cardiac Ablation Market Analysis, By End User, 2019 – 2028
10.3 Cardiac Ablation Market – North America
10.3.5 North America Market, By Product
10.3.6 North America Market, By Application
10.3.7 North America Market, By End User
10.4 Cardiac Ablation Market – Europe
10.4.7 Europe Market, By Product
10.4.8 Europe Market, By Application
10.4.9 Europe market by, End User
10.5 Cardiac Ablation Market – Asia Pacific
10.5.6 Asia Pacific Market, By Product
10.5.7 Asia Pacific Market, By Application
10.5.8 Asia Pacific Market, By End User
10.6 Cardiac Ablation Market – LAMEA
10.6.2 Middle East & Africa (MEA)
10.6.5 Latin America, Middle East and Africa Market, By Product
10.6.6 Latin America, Middle East and Africa Market, By Application
10.6.7 Latin America, Middle East and Africa Market, By End User
Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
Chapter 12 Company Profiles- Snapshot
12.1 Boston Scientific Corporation
12.2 Advanced Cardiac Therapeutics
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies”
Please fill out the form to receive sample pages of the report